| Autologous Tregs for Aplastic Anaemia (NCT05386264) | King's College Hospital NHS Trust | 2022-07-14 |
| Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function (NCT05571332) | Institute of Hematology & Blood Diseases Hospital, China | 2022-06-28 |
| An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA (NCT05333861) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-05-01 |
| GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT (NCT05510505) | The First Affiliated Hospital of Soochow University | 2021-12-30 |
| Two Step Haplo With Radiation Conditioning (NCT05031897) | Thomas Jefferson University | 2021-10-25 |
| Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia (NCT05018936) | Peking Union Medical College Hospital | 2021-10-01 |
| Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study (NCT05972577) | Ohio State University Comprehensive Cancer Center | 2021-06-11 |
| The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders. (NCT04819607) | Peter MacCallum Cancer Centre, Australia | 2021-06-09 |
| Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia (NCT04870346) | Kyowa Kirin Co., Ltd. | 2021-05-10 |
| Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy (NCT04761965) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-02-16 |
| Avatrombopag Usage in NSAA (NCT04728789) | Peking Union Medical College Hospital | 2021-02-01 |
| Haploidentical HCT for Severe Aplastic Anemia (NCT04558736) | St. Jude Children's Research Hospital | 2021-01-21 |
| National Longitudinal Cohort of Hematological Diseases (NCT04645199) | Institute of Hematology & Blood Diseases Hospital, China | 2020-12-01 |
| Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization (NCT04439006) | Jennifer Woyach | 2020-10-23 |
| TPO-Mimetic Use in Children for Hematopoietic Failure (NCT04478227) | Anjali Sharathkumar | 2020-08-18 |
| A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia (NCT04350606) | Pfizer | 2020-07-25 |
| Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients (NCT04403321) | Peking Union Medical College Hospital | 2020-07-01 |
| Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects. (NCT03988608) | Novartis Pharmaceuticals | 2019-12-09 |
| Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia (NCT04095936) | Kyowa Kirin Co., Ltd. | 2019-12-03 |
| Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia (NCT03896971) | Safaa AA Khaled | 2019-11-15 |
| Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria (NCT04128943) | University Hospital, Basel, Switzerland | 2019-11-01 |
| Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results (NCT04060485) | National Taiwan University Hospital | 2019-08-19 |
| Study of AMG531(Romiplostim) in Patients With Aplastic Anemia (NCT03957694) | Kyowa Kirin Co., Ltd. | 2019-04-25 |
| Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA (NCT03821987) | Peking University People's Hospital | 2018-12-17 |
| Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients (NCT03318159) | Seoul National University Hospital | 2018-04-20 |
| Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology (NCT06335277) | European Institute of Oncology | 2018-02-22 |
| Ambispective Observational Study to Evaluate the Incidence and Management of Aplastic Anemia in Spain (NCT04001686) | Biogipuzkoa Health Research Institute | 2018-01-31 |
| Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole (NCT03218657) | Shengyun Lin | 2018-01-01 |
| Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer (NCT03333486) | Roswell Park Cancer Institute | 2017-12-07 |
| Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation (NCT03373526) | Daniel Godoy Martinez | 2017-11-11 |
| A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT (NCT03176849) | Phoenix Children's Hospital | 2017-11-01 |
| A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia (NCT03025698) | Novartis Pharmaceuticals | 2017-09-30 |
| Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02960646) | M.D. Anderson Cancer Center | 2017-01-18 |
| Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia (NCT03055078) | Hebei Medical University | 2017-01-01 |
| King's Invasive Aspergillosis Study II (NCT02875743) | King's College Hospital NHS Trust | 2016-12-07 |
| NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia (NCT02833805) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-09-01 |
| Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload (NCT02833493) | Peking Union Medical College Hospital | 2016-09-01 |
| Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia (NCT02773290) | Kyowa Kirin Co., Ltd. | 2016-05-01 |
| Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02566304) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-11-13 |
| Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome (NCT02462252) | BioLineRx, Ltd. | 2015-10-01 |
| Umbilical Cord Blood Transplantation From Unrelated Donors (NCT03016806) | University of Rochester | 2015-06-01 |
| Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects (NCT02404025) | Novartis Pharmaceuticals | 2015-05-12 |
| Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia (NCT02162420) | Masonic Cancer Center, University of Minnesota | 2015-01-10 |
| Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease (NCT02225145) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2014-08-15 |
| A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia (NCT02203396) | Institute of Hematology & Blood Diseases Hospital, China | 2014-08-01 |
| Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients (NCT01818726) | Novartis Pharmaceuticals | 2014-06-23 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia (NCT02094417) | Kyowa Kirin Korea Co., Ltd. | 2014-04-14 |
| Nandrolone Decanoate in the Treatment of Telomeropathies (NCT02055456) | University of Sao Paulo | 2014-02-01 |
| Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination (NCT02007811) | University of Erlangen-Nürnberg Medical School | 2013-11-01 |
| Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia (NCT02028416) | National Institute of Blood Disease Center, Pakistan | 2013-09-01 |
| Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy (NCT01956799) | Fondazione Italiana Sindromi Mielodisplastiche-ETS | 2013-05-01 |
| Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) (NCT01760096) | Institute of Hematology & Blood Diseases Hospital, China | 2013-01-01 |
| Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies (NCT01760655) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-12-24 |
| Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (NCT01758042) | Massachusetts General Hospital | 2012-11-01 |
| Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria (NCT01642979) | Institute of Hematology & Blood Diseases Hospital, China | 2012-07-01 |
| Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita (NCT01659606) | Boston Children's Hospital | 2012-07-01 |
| Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome (NCT01624805) | M.D. Anderson Cancer Center | 2012-06-25 |
| Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia (NCT01995331) | Xiaofan Zhu | 2012-03-01 |
| Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01529827) | Roswell Park Cancer Institute | 2012-02-28 |
| Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match (NCT01500161) | Texas Oncology Cancer Center | 2011-11-01 |
| A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies (NCT01384513) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-08-04 |
| Alemtuzumab and Rituximab in Aplastic Anemia (NCT01408342) | Hospital Universitario Dr. Jose E. Gonzalez | 2011-07-01 |
| Alefacept in Patients With Relapsed/Refractory Aplastic Anemia (NCT01267643) | The Cleveland Clinic | 2011-05-01 |
| Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients (NCT01343680) | Alberta Children's Hospital | 2011-04-01 |
| High-Tc Susceptometer to Monitor Transfusional Iron Overload (NCT01241357) | Columbia University | 2011-03-01 |
| Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia. (NCT01305694) | Guangzhou General Hospital of Guangzhou Military Command | 2011-02-01 |
| Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia (NCT01297972) | University of Sao Paulo | 2011-02-01 |
| Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant (NCT01199562) | City of Hope Medical Center | 2010-12-01 |
| A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia (NCT01187017) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-08-01 |
| Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia (NCT01182662) | Shandong University | 2010-08-01 |
| Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia (NCT01193283) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-08-01 |
| Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia (NCT01145976) | Cooperative Study Group A for Hematology | 2010-03-01 |
| Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine (NCT00987480) | Memorial Sloan Kettering Cancer Center | 2009-09-25 |
| Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia (NCT01105273) | Asan Medical Center | 2009-07-01 |
| Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders (NCT00856388) | Roswell Park Cancer Institute | 2009-01-14 |
| Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA) (NCT00881933) | The Korean Society of Pediatric Hematology Oncology | 2008-11-01 |
| Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA) (NCT00882323) | The Korean Society of Pediatric Hematology Oncology | 2008-11-01 |
| Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia (NCT00767650) | National Heart, Lung, and Blood Institute (NHLBI) | 2008-09-23 |
| Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia (NCT00471848) | European Society for Blood and Marrow Transplantation | 2008-08-01 |
| Investigation of the Cylex® ImmuKnow® Assay (NCT00569842) | Indiana University | 2007-11-01 |
| Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones (NCT00556400) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2007-11-01 |
| Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies (NCT00673114) | Joanne Kurtzberg, MD | 2007-08-01 |
| Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA (NCT00455312) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant (NCT00354419) | Fred Hutchinson Cancer Center | 2006-02-01 |
| Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant (NCT00343785) | Fred Hutchinson Cancer Center | 2006-02-01 |
| A Phase II Study of Umbilical Cord Blood Transplantation (NCT00676806) | Tufts Medical Center | 2005-07-01 |
| Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome (NCT00806598) | M.D. Anderson Cancer Center | 2005-05-01 |
| Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia (NCT01231841) | The Cleveland Clinic | 2005-03-01 |
| Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells (NCT01919866) | University Children's Hospital Tuebingen | 2004-03-01 |
| Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia (NCT00065260) | National Heart, Lung, and Blood Institute (NHLBI) | 2003-11-06 |
| Multi Center Case Control Study on Multiple Risk Factors of Aplastic Anemia (NCT03208647) | Shengyun Lin | 2003-01-01 |
| Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia (NCT00186797) | St. Jude Children's Research Hospital | 2002-12-01 |
| Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders (NCT00533923) | Beth Israel Deaconess Medical Center | 2002-12-01 |
| Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia (NCT00578903) | Baylor College of Medicine | 2002-02-01 |
| NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders (NCT00053989) | Roswell Park Cancer Institute | 2002-01-29 |
| Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia (NCT00513175) | University of California, San Francisco | 2001-10-01 |
| Nonmyeloablative Allogeneic Transplant (NCT01272817) | Scripps Health | 2001-10-01 |
| Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia (NCT00017654) | Northwestern Memorial Hospital | 2001-04-01 |
| Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia (NCT00427336) | M.D. Anderson Cancer Center | 2000-12-01 |
| Oral Manifestations of Aplastic Anemia (NCT00006300) | National Institute of Dental and Craniofacial Research (NIDCR) | 2000-04-01 |